Moneycontrol PRO
HomeNewsBusinessMarketsOver 25 stocks lose largecap tag in market meltdown; time to buy or stay away?

Over 25 stocks lose largecap tag in market meltdown; time to buy or stay away?

Specifically, if someone is looking to buy in some of the companies from the list then Bata and PI Industries along with Gillette are looking attractive, suggest experts.

March 19, 2020 / 10:58 IST

Sensex has lost more than 30 percent so far this year, that's nearly 13,000 points, and is down about 33 percent from its record high of 42,273 registered on January 20.

The average market capitalisation of BSE-listed companies has come down by more than Rs 40 lakh cr in the same period. Tracking the sell-off in markets, nearly 30 companies have turned into midcaps from largecaps in the same period as fears of economic slowdown gripped equity markets across the globe.

We have categorized largecaps as companies with a market capitalisation of over Rs 20,000 cr as on January 1. As per the Amfi calculations, the top 100 stocks in terms of market capitalisation are classified as largecaps and the market-cap is usually over Rs 20,000 cr.

There are as many as 27 companies in BSE500 index whose market capitalisation has fallen below Rs 20,000 cr as on March 16, 2020, data from AceEquity showed. The list includes names like Adani Transmission, Adani Power, Canara Bank, Bank of India, LIC Housing, Shriram Transport, Bharat Forge Ashok Leyland, etc. among others.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Mcap 18 March

So what should investors do now? After the recent decline which is primarily led by external factors, massive wealth erosion has happened on D-Street. Does that make some of these stocks an attractive buy?

Well, experts are of the view that some of the companies which have turned midcaps from largecaps can be looked at as a buy candidate but not every stock or a company is looking attractive.

“A lot of largecaps have seen their market caps drop, purely driven by the market sentiment and external shocks. However, not all of them are Buys currently, because some of them also have lost out due to governance issues and other uncertainties,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol.

“So all of them are not automatic buys. Only those that are fundamentally strong and with higher localized business may be considered for accumulation in this market scenario,” he said.

Specifically, if someone is looking to buy in some of the companies from the list then Bata and PI Industries along with Gillette are looking attractive, suggest experts.

“Talking about the specific stocks from the list we like Bata India, PI Industries and Gillette India. We would advise investors to start accumulating these 3 stocks from the list,” Atish Matlawala, Sr Analyst, SSJ Finance & Securities told Moneycontrol.


“However, we don’t believe markets have bottomed out and do not recommend to make an entire investment in one go. There is a panic in the markets and long terms investors will definitely get a good bargain till the dust settles,” he said.


What to avoid:


Now the question is – what should they avoid especially at a time when every stock is available at a steep discount when compared to their record highs or even 52-week highs.


“Finance industry, automobiles, entertainment industry, tourism, and NBFC have gone fundamentally weak and will take at least 2 quarters to recover,” Nitin Shahi, Executive Director, Findoc Financial Services Group told Moneycontrol.


“Only selective companies have turned into midcap companies due to loss of valuation. Travel stocks should be avoided for the next one year, financial markets will take time to recover from the scare of deadly coronavirus. The best bid is to avoid stocks of travel companies, especially, focusing on Southeast Asian countries,” he said.


Nair of Geojit Financial Services is of the view that export-oriented businesses should be avoided because of the reduction in demand and trade restrictions or those companies that depend on raw materials from abroad because of supply chain issues (especially from China), will be impacted materially in the near term.


“These include sectors like Pharma, Automobiles & Ancillaries and Metals. FMCG sector is likely to see limited impact while the smaller Public Sector Banks are also likely to underperform, given the uncertainty in Investor’s mind post the Yes Bank issue and the proposed amalgamation of smaller banks,” he said.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Kshitij Anand
Kshitij Anand is the Editor Markets at Moneycontrol.
first published: Mar 19, 2020 10:58 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347